IFN-α enhances TNF-α-induced apoptosis through down-regulation of C-Myc protein expression in HL-60 cells

Journal of Experimental and Clinical Cancer Research

Volumn 24, Issue 3, 2005, Pages 447-456

  Nakashima, A ^a   Kumakura, Shunichi ^a   Mishima, S ^a   Ishikura, H ^a   Kobayashi, S ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

Apoptosis; c Myc; Differentiation; HL 60 cells; IFN ; TNF

Indexed keywords

ALPHA INTERFERON; MYC PROTEIN; PROTEIN BCL 2; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN EXPRESSION; TUMOR DIFFERENTIATION;

APOPTOSIS; CELL DIFFERENTIATION; DNA, NEOPLASM; DOWN-REGULATION; FLOW CYTOMETRY; HL-60 CELLS; HUMANS; INTERFERON-ALPHA; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-MYC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 26244431741     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Chawla-Sarkar M., Lindner D.J., Liu Y.F., et al.: Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis. Apoptosis 8:237-249, 2003.
2. Morris A., Zvetkova I.: Cytokine research: the Interferon paradigm. J. Clin. Pathol. 50:635-639, 1997.
3. Gresser I.: Wherefore interferon? J. Leukocyte Biol. 61: 567-574, 1997.
4. Strander H.: Interferon treatment of human neoplasia. Adv. Cancer. Res. 46:1-265, 1986.
5. Gutterman, J.U.: Cytokine therapeutics: lessons from interferon. Proc. Natl. Acad. Sci. USA 91:1198-1205, 1994.
6. Pfeffer L.M., Dinarello C.A., Herbermann R.B., et al.: Biological properties of recombinant α-interferons: 40th anniversary of the discovery of Interferons. Cancer Res. 58: 2489-2499, 1998.
7. Stark G.R., Kerr LM, Williams B.R.G., Silverman R.H., Schreiber R.D.: How cells respond to interferons. Ann. Rev. Biochem. 67: 227-264, 1998.
8. Upadhyaya G., Guba S.C., Sih S.A., et al.: Interferon-alpha restores the deficient expression of the cytoadhesion molecule lymphocyte function antigen-3 by chronic myelogenous leukemia progenitor cells. J. Clin. Invest. 88:2131-2136, 1991.
9. Spets H., Georgi-Hemming P., Silsajon J., Nilsson K., Jemberg Wiklund H.: Fas/Apo-1 mediated apoptosis is activated by IFN-γ and IFN-α in IL-6 dependent and IL-6 independent multiple myeloma cell lines. Blood 92: 2914-2923, 1998.
10. Selleri C., Sato T., Del Vecchio L., et al.: Involvement of Fas mediated apoptosis in the inhibitory effects of interferon alpha in chronic myelogenous leukemia. Blood 89: 957-964, 1997.
11. Dore B.T., Momparler R.L.: Effects of 5-aza-2′-deoxycytidine and interferon-alpha on differentiation and oncogene expression in HL-60 myeloid leukemic cells. Anticancer Drugs. 3:281-287, 1992.
12. Kikuchi A., Holan V., Minowada J.: Effects of tumor necrosis factor alpha, interferon alpha and interferon gamma on non-lymphoid leukemia cell lines: growth inhibition, differentiation induction and drug sensitivity modulation. Cancer Immunol. Immunother. 35:257-263, 1992.
13. Grant S., Bhalla K., Weinstein B., Pestka S., Mileno M.D., Fisher P.B.: Recombinant human interferon sensitizes resistant myeloid leukemic cells to induction of terminal differentiation. Biochem. Biophys. Res. Commun. 130:379-388, 1985.
14. Yasuoka Y., Naomoto Y., Yamatsuji T., et al.: Combination of tumor necrosis factor alpha and interferon alpha induces apoptotic cell death through a c-myc-dependent pathway in p53 mutant H226br non-small-cell lung cancer cell line. Exp. Cell. Res. 271:214-222, 2001.
15. Darnell J.E. Jr., Kerr I.M., Stark G.R.: Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264: 1415-1421, 1994.
16. Leaman D.W., Chawla-Sarkar M., Jacobs B., et al.: Novel growth and death related interferon-stimulated genes (ISGs) in melanoma: greater potency of IFN-beta compared with IFN-alpha2. J Interferon Cytokine Res. 23:745-756, 2003.
17. Platanias L.C., Sweet M.E.: Interferon alpha induces rapid tyrosine phosphorylation of the vav proto-oncogene product in hematopoietic cells. J. Biol. Chem. 269:3143-3146, 1994.
18. Kumar A., Atlad I.: Interferon-α induces the expression of retinoblastoma gene product in human burkitt lymphoma Daudi cells: Role in growth regulation. Proc. Natl. Acad. Sci. USA 89:6599-6603, 1992.
19. Tienfenbrun N., Melamed D., Levy N.: Alpha interferon suppresses the cyclin D3 and cdc25A genes, leading to reversible G0-like arrest. Mol. Cell. Biol. 16:3934-3944, 1996.
20. 1 arrest, differentiation and apoptosis of the Daudi B-cell line. Oncogene 16: 1885-1890, 1998.
21. Xu D., Erickson S., Szeps M., et al.: Interferon alpha down-regulates telomerase reverse transcriptase and telomerase activity in human malignant and nonmalignant hematopoietic cells. Blood 96:4313-4318, 2000.
22. 1 arrest. Nature 313:597-600, 1985.
23. Harvey W.H., Harb O.S., Kosak S.T., Sheaffer J.C., Lowe L.R., Heerema N.A.: Interferon-alpha-2b downregulation of oncogenes H-ras, c-raf-2, c-kit, c-myc, c-myb and c-fos in ESKOL, a hairy cell leukemic line, results in temporal perturbation of signal transduction cascade. Leuk. Res. 18:577-585, 1994.
24. Panayiotidis P., Ganeshaguru K., Jabbar S.A., Hoffbrand A.V.: Alpha-interferon (alpha-IFN) protects B-chronic lymphocytic leukaemia cells from apoptotic cell death in vitro. Br. J. Haematol. 86:169-173, 1994.
25. Khalaf W., Maina C., Byers J., Harvey W.: Interferon-alpha 2b and vesnarinone influence levels of tumor necrosis factor-alpha, apoptosis, or interleukin 6 in ESKOL, a hairy cell leukemic cell line. A potential cytokine and oncogene relationship regulating apoptosis is suggested. Leuk. Res. 26:169-177, 2002.
26. Kumakura S., Ishikura H., Tsumura H., Iwata Y., Endo J., Kobayashi S.: C-Myc and Bcl-2 protein expression during the induction of apoptosis and differentiation in TNF-α-treated HL-60 cells. Leuk. Lymphoma 23:383-394, 1996.
27. Prendergast G.G.: Mechanisms of apoptosis by c-Myc. Oncogene 18:2967-2987, 1999.
28. Rustgi, A.K., Dyson N., Bernards R.: Aminoterminal domains of c-myc and N-myc proteins mediate binding to the retinoblastoma gene product. Nature 352:541-544, 1991.
29. 1. Nature 328:445-449, 1987.
30. Kumakura S., Ishikura H., Tsumura H., Hayashi H., Endo J. Tsunematsu T.: c-myc protein expression during cell cycle phases in differentiating HL-60 cells. Leuk. Lymphoma 14:171-180, 1994.
31. Evan G.I., Wyllie A.H., Gilbert C.S., et al.: Induction of apoptosis in fibroblasts by c-myc protein. Cell 69:119-128, 1992.
32. Askew D.S., Ashmun R.A., Simmons B.C., Cleveland J.L.: Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene 6:1915-1922, 1991.
33. Shi Y., Glynn J.M., Guilbert L.J., Cotter T.G., Bissonnette R.P., Green D.R.: Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas. Science 257:212-214, 1992.
34. Bissonnette R.P., Echeverri F., Mahboubi A., Green D.R.: Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature 359:552-554, 1992.
35. Fanidi A., Harrington E.A., Evan G.I.: Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature 359:554-556, 1992.
36. Askew D.S., Ihle J.N., Cleveland J.L.: Activation of apoptosis associated with enforced Myc expression in myeloid progeniter cells is dominant to the suppression of apoptosis by interleukin-3 or erythropoietin. Blood 82:2079-2087, 1993.
37. Cleary M.L., Sklar J.: Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18. Proc. Natl. Acad. Sci. USA 82:7439-7443, 1985.
38. Tsujimoto Y., Croce C.M.: Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc. Natl. Acad. Sci. USA 83:5214-5218, 1985.
39. Bakhshi A., Jensen J.P., Goldman P., et al.: Cloning the chromosomal breakpoint of t(14;18) human lymphomas: Clustering around JH on chromosome 14 and near a transcriptional unit on 18. Cell 41:889-906, 1985.
40. Hockenbery D., Nuñez G., Mlliman C., et al.: bcl-2 is an inner mitochondrial menbrane protein that blocks programmed cell death. Nature 348:334-336, 1990.
41. Krajewski S., Tanaka S., Takayama S., Schibler M.J., Fenton W., Reed J.C.: Investigations of the subcellular distribution of the BCL-2 oncoprotein: residence in the nuclear envelope, endoplastic reticulum, and outer mitochondrial membranes. Cancer Res. 53:4701-4714, 1993.
42. Vaux D.L., Cory S., Adems J.M.: Bcl-2 gene promotes haematopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335:440-442, 1988.
43. Korsmeyer S.J.: Bcl-2 initiates a new category of oncogenes: regulation of cell death. Blood 80:879-886, 1992.
44. Reed J.C.: Bcl-2 and the regulation of programmed cell death. J. Cell. Biol. 124:1-6, 1994.
45. Evan G., Lewis G.K., Ramsay G., Bishop J.M.: Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. Mol. Cell. Biol. 5:3610-3616, 1985.
46. Pezzella F., Tes A.G.D., Cordell J.L., Pulford K.A.F., Gatter K.C., Mason D. Y: Expression of the bcl-2 oncogene protein is not specific for the 14; 18 chromosomal translocation. Am. J. Pathol. 137:225-232, 1990.
47. Balkwill F., Taylor-Papadinitriou J.: Interferon affects both G1 and S+G2 in cells stimulated from quiescence to growth. Nature 274:798-800, 1978.
48. Iwase S., Furukawa Y., Kikuchi J., et al.: Modulation of E2F activity is linked to interferon-induced growth suppression of hematopoietic cells. J. Biol. Chem. 272:12406-12414, 1997.
49. Trudel M., Lanoix J., Barisoni L., et al.: C-myc-induced apoptosis in polycystic kidney disease is Bcl-2 and p53 independent. J. Exp. Med. 186:1873-1884, 1997.
50. Melamed D., Tiefenbrun N., Yarden A., Kimchi A.: Interferons and interleukin-6 suppress the DNA-binding activity of E2F in growth-sensitive hematopoietic cells. Mol. Cell. Biol. 13:5255-5265, 1993.
51. Beijersbergen R.L., Bernards R.: Cell cycle regulation by the retinoblastoma family of growth inhibitory proteins. Biochim. Biophys. Acta. 1287:103-120, 1996.
52. Iakova P., Awad S.S., Timchenko N.A.: Aging reduces proliferative capacities of liver by switching pathways of C/EBPalpha growth arrest. Cell 113:495-506, 2003.
53. Griffith T.S., Wiley S.R., Kubin M.Z., Sedger L.M., Maliszewski C.R., Fanger N.A.: Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine, TRAIL. J. Exp. Med. 189:1343-1354, 1999.
54. Kayagaki N., Yamaguchi N., Nakayama M., Eto H., Okumura K., Yagita H.: Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of type I IFNs. J. Exp. Med. 189:1451-1460, 1999.
55. Oshima K., Yanase N., Ibukiyama C., et al.: Involvement of TRAIL/TRAIL-R interaction in IFN-alpha-induced apoptosis of Daudi B lymphoma cells. Cytokine 14:193-201, 2001.
56. Chen Q., Gong B., Mahmoud-Ahmed A.S., et al.: Apo2L/TRAIL and Bcl2 related proteins regulate type I interferon induced apoptosis in multiple myeloma. Blood 98: 2183-2192, 2001.
57. Danial N.N., Korsmeyer S.J.: Cell death: critical control points. Cell 116:205-219, 2004.
58. Shivapurkar N., Reddy J., Matta H., et al.: Loss of expression of death-inducing signaling complex (DISC) components in lung cancer cell lines and the influence of MYC amplication. Oncogene 21:8510-8514, 2002.